Susan G. Komen Blog

Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

A woman with a shaved head following triple negative breast cancer recurrence wears a pink floral dress while sitting on a bench in front of a white grand piano.

Kristen’s Story: Running Toward Hope While Facing Breast Cancer Again

Kristen Dugan worked hard to rebuild her life after breast cancer treatment when a triple negative breast cancer (TNBC) recurrence changed everything. As she returned to treatment, Kristen remained determined to continue training to run the TCS New York City Marathon with Team Komen while serving as the chair of the 2027 Komen West Palm Beach MORE THAN PINK Walk.

Breast Cancer Breakthroughs Episode 25: What’s New for HR+ Metastatic Breast Cancer? 

We’ve seen remarkable progress in treating hormone receptor-positive (HR+) metastatic breast cancer (MBC), with numerous new targeted therapies becoming available in recent years. But the work isn’t over yet.  In this episode of Breast Cancer Breakthroughs, we are joined by MBC patient advocate Bethany Adair; Komen grantee and medical oncologist Sonya Reid, M.D.; and medical […]

A New Era in MBC Care: Understanding the SERENA-6 Approval and ctDNA-Guided Treatment Switching 

The recent FDA approval stemming from the SERENA-6 clinical trial may usher in a new era in metastatic breast cancer (MBC) care. Evidence from the trial showed how a simple blood test using circulating tumor DNA (ctDNA) can help doctors guide treatment decisions for metastatic breast cancer (MBC). ctDNA testing can detect molecular changes in […]

Wynter’s Story: Finding Gratitude While Living with Metastatic Breast Cancer 

For Wynter, life is measured in moments. Time spent with family, days on the water fishing, opportunities to travel and ordinary experiences that have taken on new meaning since her breast cancer diagnosis.  Diagnosed with triple positive breast cancer in 2022 at age 41, Wynter is now living with stage 4 metastatic breast cancer (MBC). […]

From Research to Real Lives: How Komen’s Center for Public Policy Champions Improved Access to Breast Cancer Drugs 

Over the last few decades, more lives have been saved from breast cancer, thanks to early detection and increasingly personalized and innovative treatments. These advances contributed to a 44% decline in the breast cancer death rate in the U.S. between 1989 and 2024. Future progress that impacts real lives depends on breakthroughs in research, driven […]

ESMO Congress 2026: Addressing Five Questions in Breast Cancer Research  

At the European Society for Medical Oncology (ESMO) Congress 2026, experts addressed five outstanding questions in breast cancer research, paving the ever-growing path to more personalized care. Last year’s ESMO Congress delivered a wave of phase 3 clinical trial results, and this year thousands of experts gathered in Madrid with more answers from many of […]

Debunking 5 Common Mammogram Myths 

Mammography is the most effective screening test used today to find breast cancer in most women. Regular screening mammography (along with follow-up tests and treatment, if diagnosed) reduces the chance of dying from breast cancer. Below, we’re debunking seven of the most common mammogram myths, so you have the facts you need to make informed screening […]